A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
| Member | Definition | Class |
|---|
| 3-methylfentanyl | The monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of 3-methyl-N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid. | 3-methylfentanyl |
| 4-hydroxybutyric acid | A 4-hydroxy monocarboxylic acid that is butyric acid in which one of the hydrogens at position 4 is replaced by a hydroxy group. | 4-hydroxybutyric acid |
| adinazolam | A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. | adinazolam |
| alprazolam | A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. | alprazolam |
| benzquinamide | | benzquinamide |
| brexanolone | A 3-hydroxy-5alpha-pregnan-20-one in which the hydroxy group at position 3 has alpha-configuration. It is a metabolite of the sex hormone progesterone and used for the treatment of postpartum depression in women. | brexanolone |
| buspirone | An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position. | buspirone |
| buspirone hydrochloride | A hydrochloride salt resulting from the reaction of equimolar amounts of buspirone and hydrogen chloride. | buspirone hydrochloride |
| butalbital | A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache. | butalbital |
| chloral hydrate | An organochlorine compound that is the hydrate of trichloroacetaldehyde. | chloral hydrate |
| chlorzoxazone | A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm. | chlorzoxazone |
| dexmedetomidine | | dexmedetomidine |
| diazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. | diazepam |
| didesethylflurazepam | A primary amino compound resulting from the dealkylation of both ethyl groups of the anti-insomnia drug flurazepam. It is the major metabolite of flurazepam. | didesethylflurazepam |
| diphenhydramine | An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. | diphenhydramine |
| diphenhydramine hydrochloride | The hydrochloride salt of diphenhydramine. | diphenhydramine hydrochloride |
| doxylamine | | doxylamine |
| eszopiclone | The (5S)- (active) enantiomer of zopiclone. Unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia, eszopiclone is approved by the U.S. Food and Drug Administration for long-term use. | eszopiclone |
| ethinamate | A carbamate ester that is the 1-vinylcyclohexyl ester of carbamic acid. A short-acting sedative-hypnotic, it was formerly used to treat insomnia. | ethinamate |
| etomidate | The ethyl ester of 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylic acid. It is an intravenous general anaesthetic with no analgesic activity. | etomidate |
| etorphine | | etorphine |
| fenadiazole | A biaryl that is phenol which is substituted at position 2 by a 1,3,4-oxadiazol-2-yl group. Formerly used as a hypnotic drug. | fenadiazole |
| flunitrazepam | A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia. | flunitrazepam |
| flurazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a 2-(diethylamino)ethyl group, 2-fluorophenyl group and chloro group at positions 1, 5 and 7, respectively. It is a partial agonist of GABAA receptors and used for the treatment of insomnia. | flurazepam |
| lactucin | An azulenofuran that is 3-methylidene-3,3a,4,5,9a,9b-hexahydroazuleno[4,5-b]furan-2,7-dione carrying additional hydroxy, methyl and hydroxymethyl substituents at positions 4, 6 and 9 respectively (the 3aR,4S,9aS,9bR-diastereomer). Found in chicory. | lactucin |
| lormetazepam | A 1,4-benzodiazepinone compound having a methyl substituent at the 1-position, a hydroxy substituent at the 3-position, a 2-chlorophenyl group at the 5-position and a chloro substituent at the 7-position. | lormetazepam |
| methapyrilene | A member of the class of ethylenediamine derivatives that is ethylenediamine in which one of the nitrogens is substituted by two methyl groups, and the other nitrogen is substituted by a 2-pyridyl group and a (2-thienyl)methyl group. | methapyrilene |
| methapyrilene hydrochloride | A hydrochloride that is the monohydrochloride salt of methapyrilene. | methapyrilene hydrochloride |
| methaqualone | A member of the class of quinazolines that is quinazolin-4-one substituted at positions 2 and 3 by methyl and o-tolyl groups respectively. A depressant that increases the activity of the GABA receptors in the brain and nervous system, it is used as a sedative and hypnotic medication. It became popular as a recreational drug and club drug in the late 1960s and 1970s. | methaqualone |
| mianserin | A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere. | mianserin |
| midazolam | An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively. | midazolam |
| midazolam hydrochloride | The hydrochloride salt of midazolam. | midazolam hydrochloride |
| nimetazepam | A nitrazepam which is substituted at positions 1 by a methyl group. It is used as an anticonvulsant and as a hypnotic for the short-term management of insomnia. | nimetazepam |
| nitrazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). | nitrazepam |
| nordazepam | A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. | nordazepam |
| paraldehyde | A trioxane that is 1,3,5-trioxane substituted by methyl groups at positions 2, 4 and 6. | paraldehyde |
| periciazine | A member of the class of phenothiazines that is 10H-phenothiazine substituted by a 3-(4-hydroxypiperidin-1-yl)propyl group at the nitrogen atom and a carbonitrile group at position 2. Periciazine is a first generation antipsychotic. | periciazine |
| phenobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. | phenobarbital |
| pregnanolone | The 3alpha-stereoisomer of 3-hydroxy-5beta-pregnan-20-one. | 3alpha-hydroxy-5beta-pregnan-20-one |
| promethazine | A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety. | promethazine |
| promethazine hydrochloride | The hydrochloride salt of promethazine. | promethazine hydrochloride |
| propiomazine | A member of the class of phenothiazines that is 10H-phenothiazine substituted by a 2-(dimethylamino)propyl group at nitrogen atom and a propanoyl group at position 2. | propiomazine |
| propofol | A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group. | propofol |
| remifentanil | A piperidinecarboxylate ester that is methyl piperidine-4-carboxylate in which the hydrogen attached to the nitrogen is substituted by a 3-methoxy-3-oxopropyl group and the hydrogen at position 4 is substituted the nitrogen of N-propanoylaniline. | remifentanil |
| secobarbital | A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by prop-2-en-1-yl and pentan-2-yl groups. | secobarbital |
| terpinolene | A p-menthadiene with double bonds at positions 1 and 4(8). | terpinolene |
| thiamylal | A member of the class of barbiturates that is 2-thioxodihydropyrimidine-4,6(1H,5H)-dione substituted by a pentan-2-yl and prop-2-en-1-yl group at position 5. | thiamylal |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. | thiopental |
| trazodone | An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group. | trazodone |
| trazodone hydrochloride | A hydrochloride salt prepared from equimolar amounts of trazodone and hydrogen chloride. | trazodone hydrochloride |
| triazolam | | triazolam |
| valerenic acid | A monocarboxylic acid that is 2-methylprop-2-enoic acid which is substituted at position 3 by a 3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl group. A bicyclic sesquiterpenoid constituent of the essential oil of the Valerian plant. | valerenic acid |
| xylazine | A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties. | xylazine |
| zaleplon | A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position. | zaleplon |
| zolpidem | An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position. | zolpidem |
| zopiclone | A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position. | zopiclone |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 23.8943 | 1 | 8 |
| 67.9K protein | Vaccinia virus | Potency | 3.2657 | 2 | 3 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 36.0999 | 3 | 14 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 0.1294 | 1 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 18.7252 | 1 | 12 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 3.5481 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 29.4808 | 9 | 78 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 26.4638 | 2 | 9 |
| arylsulfatase A | Homo sapiens (human) | Potency | 10.4193 | 1 | 5 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 23.7758 | 3 | 4 |
| Ataxin-2 | Homo sapiens (human) | Potency | 26.2997 | 2 | 11 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 16.6662 | 1 | 5 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 29.9323 | 2 | 14 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 37.9330 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 94.7958 | 2 | 6 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 48.4331 | 1 | 3 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 68.4850 | 1 | 2 |
| caspase-3 | Homo sapiens (human) | Potency | 68.4850 | 1 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 31.6878 | 2 | 19 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 26.0284 | 1 | 9 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 1.4125 | 1 | 1 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 31.8476 | 3 | 7 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 27.1672 | 2 | 5 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 64.7758 | 1 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 7.2132 | 1 | 5 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 27.1672 | 2 | 5 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 74.5741 | 2 | 10 |
| ClpP | Bacillus subtilis | Potency | 31.6228 | 1 | 1 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 5.0119 | 1 | 1 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 15.9845 | 1 | 3 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 25.4764 | 1 | 5 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 13.7710 | 1 | 12 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 13.5269 | 1 | 10 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 13.5052 | 2 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 17.1025 | 2 | 16 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 25.3811 | 1 | 12 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 6.2235 | 2 | 8 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 14.6892 | 1 | 1 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 62.1162 | 1 | 5 |
| endonuclease IV | Escherichia coli | Potency | 50.1187 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 31.8414 | 10 | 94 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 47.7260 | 2 | 8 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 38.2409 | 7 | 61 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 24.4178 | 2 | 24 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 25.2425 | 4 | 9 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 32.0344 | 2 | 4 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 0.1889 | 1 | 1 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 37.2212 | 1 | 1 |
| G | Vesicular stomatitis virus | Potency | 25.4764 | 1 | 5 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 13.5052 | 1 | 7 |
| geminin | Homo sapiens (human) | Potency | 9.7916 | 3 | 16 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 21.0979 | 2 | 28 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 14.7334 | 1 | 2 |
| GLS protein | Homo sapiens (human) | Potency | 16.9695 | 2 | 7 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 18.7871 | 4 | 30 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 42.2229 | 1 | 6 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 7.9433 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 49.0276 | 2 | 3 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 18.3695 | 2 | 13 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 29.1323 | 1 | 6 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 98.2550 | 1 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 70.7946 | 1 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 25.4764 | 1 | 5 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 33.0488 | 1 | 3 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 4.8966 | 1 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 15.7217 | 2 | 8 |
| IDH1 | Homo sapiens (human) | Potency | 7.6224 | 1 | 2 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 25.4764 | 1 | 10 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 3.5559 | 1 | 5 |
| Interferon beta | Homo sapiens (human) | Potency | 25.4764 | 1 | 5 |
| interleukin 8 | Homo sapiens (human) | Potency | 74.9780 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 8.0143 | 1 | 19 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 12.5893 | 1 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 26.0159 | 2 | 3 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 33.2451 | 1 | 2 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 3.9854 | 1 | 2 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 17.1098 | 2 | 7 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 13.3872 | 2 | 10 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 6.5955 | 1 | 4 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 25.1189 | 1 | 2 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 1.7783 | 2 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 41.9774 | 3 | 14 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 25.9290 | 1 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 19.0432 | 1 | 5 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 37.5780 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 3.8254 | 1 | 4 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 47.1016 | 3 | 19 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 125.8920 | 1 | 1 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 15.4796 | 2 | 8 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 84.9214 | 1 | 3 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 32.3203 | 5 | 12 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 38.8088 | 5 | 14 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 66.8227 | 3 | 6 |
| polyprotein | Zika virus | Potency | 37.2212 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 23.7358 | 1 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 11.3454 | 1 | 13 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 25.5015 | 3 | 28 |
| progesterone receptor | Homo sapiens (human) | Potency | 27.3673 | 2 | 13 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 24.6167 | 2 | 14 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 30.7980 | 1 | 2 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 11.4382 | 1 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 36.4319 | 3 | 24 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 34.4819 | 3 | 11 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 14.6892 | 2 | 2 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 35.6465 | 2 | 4 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 35.6465 | 2 | 4 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 27.1699 | 1 | 5 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 1.2673 | 1 | 2 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 8.2400 | 1 | 2 |
| TDP1 protein | Homo sapiens (human) | Potency | 26.0558 | 2 | 29 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 39.3247 | 3 | 10 |
| Thrombopoietin | Homo sapiens (human) | Potency | 0.0945 | 2 | 4 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 38.0997 | 3 | 48 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 3.5481 | 1 | 1 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 30.0692 | 4 | 12 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 16.0516 | 2 | 2 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 65.7897 | 1 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 24.8080 | 2 | 23 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 39.0014 | 3 | 10 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 71.2925 | 1 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 42.2229 | 1 | 6 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | IC50 | 0.2737 | 3 | 3 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 0.7689 | 9 | 13 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.0388 | 29 | 30 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 7.7260 | 15 | 21 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 5.1136 | 4 | 7 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 1.0708 | 5 | 8 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | IC50 | 0.3802 | 2 | 2 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | IC50 | 3.0000 | 2 | 2 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.8400 | 2 | 2 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | IC50 | 3.0000 | 2 | 2 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.8400 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 0.4595 | 5 | 10 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 2.5042 | 7 | 8 |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | Ki | 0.1780 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.2705 | 13 | 20 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.3994 | 8 | 8 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 1.1989 | 1 | 7 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 2.0000 | 5 | 5 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.7628 | 1 | 7 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.5387 | 5 | 5 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 1.9127 | 2 | 7 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 1.8333 | 6 | 6 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.6654 | 7 | 14 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.4491 | 6 | 6 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | IC50 | 1.4125 | 2 | 2 |
| 5-hydroxytryptamine receptor 3A | Mus musculus (house mouse) | IC50 | 1.4125 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Mus musculus (house mouse) | Ki | 0.2520 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | Ki | 0.0700 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | IC50 | 1.4125 | 2 | 2 |
| 5-hydroxytryptamine receptor 3B | Mus musculus (house mouse) | IC50 | 1.4125 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Mus musculus (house mouse) | Ki | 0.2520 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | Ki | 0.0700 | 1 | 1 |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | IC50 | 1.4125 | 2 | 2 |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | IC50 | 1.4125 | 2 | 2 |
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | IC50 | 1.4125 | 2 | 2 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 2.2302 | 1 | 6 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 1.1680 | 1 | 6 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 1.8683 | 1 | 3 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.5340 | 3 | 5 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 35.1000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 0.1148 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 1.7962 | 5 | 5 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | IC50 | 5.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0816 | 2 | 2 |
| Acetylcholine receptor subunit alpha | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholine receptor subunit alpha | Tetronarce californica (Pacific electric ray) | IC50 | 41.0000 | 1 | 1 |
| Acetylcholine receptor subunit beta | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholine receptor subunit beta | Tetronarce californica (Pacific electric ray) | IC50 | 41.0000 | 1 | 1 |
| Acetylcholine receptor subunit delta | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholine receptor subunit delta | Tetronarce californica (Pacific electric ray) | IC50 | 41.0000 | 1 | 1 |
| Acetylcholine receptor subunit gamma | Mus musculus (house mouse) | IC50 | 50.0000 | 1 | 1 |
| Acetylcholine receptor subunit gamma | Tetronarce californica (Pacific electric ray) | IC50 | 41.0000 | 1 | 1 |
| Acetylcholinesterase | Bos taurus (cattle) | IC50 | 7.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 3.7454 | 1 | 5 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 3.7146 | 1 | 5 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | IC50 | 0.4074 | 2 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.1656 | 6 | 11 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.1326 | 6 | 8 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.6821 | 5 | 10 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.1484 | 5 | 7 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 0.4020 | 1 | 4 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.6821 | 5 | 10 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.1580 | 2 | 5 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.1484 | 5 | 7 |
| Alpha-2A adrenergic receptor | Bos taurus (cattle) | IC50 | 0.0250 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 0.4698 | 3 | 6 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 6.2420 | 3 | 5 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 0.1762 | 3 | 6 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.8465 | 6 | 6 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 0.7624 | 2 | 5 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 6.2420 | 3 | 5 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 0.4352 | 1 | 4 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.6913 | 3 | 3 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 0.7729 | 4 | 6 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 6.2420 | 3 | 5 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 0.1391 | 3 | 5 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.6913 | 3 | 3 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 3.0000 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 31.8590 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 26.1013 | 1 | 1 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | Ki | 0.5000 | 1 | 3 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 0.0240 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 13.6450 | 1 | 2 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 9 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 50.0000 | 3 | 3 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 41.5000 | 4 | 4 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 235.5250 | 6 | 28 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 684.9000 | 1 | 2 |
| Calcium release-activated calcium channel protein 1 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | Ki | 4.3000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | Ki | 19.4333 | 3 | 3 |
| Calmodulin-1 | Homo sapiens (human) | IC50 | 60.0000 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 6 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 98.9000 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 19.5000 | 1 | 1 |
| Chloroquine resistance transporter | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 85.0000 | 1 | 1 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | IC50 | 51.5000 | 1 | 2 |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | IC50 | 83.8333 | 3 | 6 |
| Cholinesterase | Equus caballus (horse) | IC50 | 0.2300 | 1 | 1 |
| Cytochrome P450 11B1, mitochondrial | Homo sapiens (human) | IC50 | 0.0005 | 4 | 4 |
| Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | IC50 | 0.0009 | 4 | 4 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 2.7564 | 1 | 1 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 2.7427 | 3 | 3 |
| D | Bos taurus (cattle) | IC50 | 270.0000 | 1 | 2 |
| D | Rattus norvegicus (Norway rat) | IC50 | 0.1200 | 1 | 2 |
| D | Mus musculus (house mouse) | Ki | 1.0000 | 1 | 1 |
| D | Rattus norvegicus (Norway rat) | Ki | 1.4200 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 1.6435 | 1 | 2 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 0.8215 | 1 | 2 |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1200 | 1 | 2 |
| D(2) dopamine receptor | Bos taurus (cattle) | IC50 | 4.0000 | 2 | 3 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 3.3077 | 5 | 6 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 1.0412 | 7 | 8 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.5166 | 8 | 9 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.8094 | 4 | 5 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 2.4254 | 3 | 5 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1200 | 1 | 2 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 1.0792 | 2 | 4 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 1.5240 | 1 | 1 |
| D(4) dopamine receptor | Homo sapiens (human) | IC50 | 3.3113 | 2 | 2 |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1200 | 1 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0074 | 1 | 2 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 0.0029 | 2 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Endothelin receptor type B | Homo sapiens (human) | Ki | 0.0631 | 2 | 2 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Ki | 0.0631 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | IC50 | 0.1148 | 1 | 1 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 57.7655 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 52.0000 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 1,007.0000 | 1 | 2 |
| G-protein coupled receptor | Apis mellifera (honey bee) | IC50 | 73.0000 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | IC50 | 53,972.4584 | 8 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | IC50 | 0.0483 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 0.9032 | 19 | 59 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 25.6752 | 31 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 0.9922 | 16 | 55 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 32.5805 | 24 | 31 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 1.0192 | 18 | 58 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 31.5299 | 24 | 32 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 2.1193 | 4 | 32 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | IC50 | 74,129.5074 | 5 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 2.8228 | 13 | 50 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 36.6655 | 21 | 28 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 3.5053 | 9 | 41 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 32.0023 | 24 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 0.0212 | 3 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | IC50 | 74,201.6303 | 5 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 1.7920 | 16 | 56 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 17.4345 | 45 | 62 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | IC50 | 53,920.0054 | 8 | 11 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 1.4281 | 40 | 77 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 39.1009 | 20 | 26 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 2.4648 | 30 | 52 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | IC50 | 49,474.7549 | 9 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 1.5817 | 55 | 133 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 16.5302 | 47 | 66 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 2.5130 | 29 | 51 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 45.7531 | 18 | 22 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | IC50 | 84,719.4346 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | Ki | 79.0000 | 1 | 6 |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | IC50 | 0.0802 | 3 | 7 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0000 | 1 | 2 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 0.0115 | 3 | 7 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.8800 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 1.0865 | 1 | 2 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 1.0690 | 1 | 2 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 42.6579 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0018 | 1 | 1 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 0.0005 | 2 | 2 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0002 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
| Lysosomal alpha-glucosidase | Bos taurus (cattle) | IC50 | 0.0300 | 1 | 1 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 2.6430 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0004 | 2 | 2 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.2002 | 4 | 5 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 1.7000 | 1 | 1 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 46.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 9 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 1.6390 | 1 | 4 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | IC50 | 0.2300 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 0.3948 | 1 | 4 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 0.9570 | 1 | 4 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 0.2300 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 0.3400 | 1 | 4 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 0.6907 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | IC50 | 0.2300 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 0.1464 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 0.8152 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 0.2300 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 0.1137 | 1 | 3 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.9379 | 1 | 4 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | IC50 | 1.0650 | 2 | 2 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 0.6738 | 1 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.0100 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.0100 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 31.8590 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 26.1013 | 1 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | Saccharomyces cerevisiae S288C | IC50 | 17.7000 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 7.5960 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 916.4257 | 8 | 10 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 26.1013 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 13.6450 | 1 | 2 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 3.8320 | 1 | 1 |
| Protein orai-2 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| Protein orai-3 | Homo sapiens (human) | IC50 | 500.0000 | 2 | 2 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 65,000.0000 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 13.6450 | 1 | 2 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 13.6450 | 1 | 2 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 13.6450 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 13.6450 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 13.6450 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | IC50 | 10.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | IC50 | 0.5927 | 3 | 6 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 0.9213 | 2 | 4 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 41.0000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 9.5020 | 1 | 4 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 9.5020 | 1 | 4 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 9.5020 | 1 | 4 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 9.5020 | 1 | 4 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 2.7570 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 2.1900 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 3.7454 | 1 | 5 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 3.7146 | 1 | 5 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 2.8120 | 2 | 5 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 2.9000 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 0.8590 | 1 | 4 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | IC50 | 24.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 35.1000 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | Ki | 3.7000 | 1 | 1 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | IC50 | 32.0000 | 1 | 1 |
| Sphingosine-1-phosphate lyase 1 | Mus musculus (house mouse) | Ki | 0.3900 | 1 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 13.6450 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 13.6450 | 1 | 2 |
| Tetraspanin | Rattus norvegicus (Norway rat) | IC50 | 15.8000 | 2 | 2 |
| Translocator protein | Homo sapiens (human) | IC50 | 148,259.0000 | 1 | 4 |
| Translocator protein | Rattus norvegicus (Norway rat) | IC50 | 4.7000 | 1 | 1 |
| Translocator protein | Bos taurus (cattle) | Ki | 0.0009 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | Ki | 0.0034 | 2 | 2 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 13.6450 | 1 | 2 |
| Transporter | Rattus norvegicus (Norway rat) | IC50 | 13.6813 | 2 | 3 |
| Transporter | Rattus norvegicus (Norway rat) | Ki | 0.1010 | 1 | 1 |
| Trypanothione reductase | Trypanosoma cruzi | IC50 | 271.0000 | 1 | 1 |
| Trypanothione reductase | Trypanosoma cruzi | Ki | 216.0000 | 1 | 1 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2100 | 1 | 1 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.5000 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 200.2222 | 1 | 9 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 200.2222 | 1 | 9 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 200.2222 | 1 | 9 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 200.2222 | 1 | 9 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 200.2222 | 1 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 30.5000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 30.5000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 30.5000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 30.5000 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 18.0000 | 1 | 1 |